Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation

The objective of this study was to compare outcomes between basiliximab and low-dose r-ATG in living donor kidney transplantation recipients with low immunological risk. Patients in the low-dose r-ATG group received 1.5 mg/kg of r-ATG for 3 days (total 4.5 mg/kg). Graft survival, patient survival, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang Jin, Rhu, Jinsoo, Yoo, Heejin, Kim, Kyunga, Lee, Kyo Won, Park, Jae Berm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290680/
https://www.ncbi.nlm.nih.gov/pubmed/32370265
http://dx.doi.org/10.3390/jcm9051320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290680/
https://www.ncbi.nlm.nih.gov/pubmed/32370265
http://dx.doi.org/10.3390/jcm9051320

Ejemplares similares